Thyroid hormone imbalance leading to neurodevelopmental abnormalities (Homo sapiens)
From WikiPathways
Description
Adverse Outcome Pathway for the effect of thyroid hormone disruption
Please use the New WikiPathways
View approved pathways at the new wikipathways.org. This website will shutdown soon.Quality Tags
Ontology Terms
Bibliography
- Sauer UG, Asiimwe A, Botham PA, Charlton A, Hallmark N, Jacobi S, Marty S, Melching-Kollmuss S, Palha JA, Strauss V, van Ravenzwaay B, Swaen G; ''Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part I: which parameters from human studies are most relevant for toxicological assessments?''; Crit Rev Toxicol, 2020 PubMed Europe PMC Scholia
- Marty S, Beekhuijzen M, Charlton A, Hallmark N, Hannas BR, Jacobi S, Melching-Kollmuss S, Sauer UG, Sheets LP, Strauss V, Urbisch D, Botham PA, van Ravenzwaay B; ''Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments?''; Crit Rev Toxicol, 2021 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| BDNF signaling pathway | Pathway | WP2380 (WikiPathways) ![]() | |
| CaMKK2 signaling pathway | Pathway | WP5231 (WikiPathways) ![]() | |
| GABA receptor signaling pathway | Pathway | WP4159 (WikiPathways) ![]() | |
| KE277: Decrease thyroid hormone synthesis | Key Event | 277 (AOP-Wiki) ![]() | |
| KE279: Thyroperoxidase inhibition | Key Event | 279 (AOP-Wiki) ![]() | |
| KE280:Decreased T4 in neuronal tissue | Key Event | 280 (AOP-Wiki) ![]() | |
| KE281:Decreased T4 in serum | Key Event | 281 (AOP-Wiki) ![]() | |
| KE319: loss of cochlear function | Key Event | 319 (AOP-Wiki) ![]() | |
| KE341: Learning and memory impairment | Key Event | 341 (AOP-Wiki) ![]() | |
| KE381:Reduced levels of BDNF | Key Event | 381 (AOP-Wiki) ![]() | |
| KE385: Decreased synaptogenesis | Key Event | 385 (AOP-Wiki) ![]() | |
| KE386: Decreased neuronal network function | Key Event | 386 (AOP-Wiki) ![]() | |
| KE424: NIS inhibition | Key Event | 424 (AOP-Wiki) ![]() | |
| KE425: Decrease of Thyroidal Iodide | Key Event | 425 (AOP-Wiki) ![]() | |
| KE42: Decreased cognitive function | Key Event | 42 (AOP-Wiki) ![]() | |
| KE756:Altered hippocampal gene expression | Key Event | 756 (AOP-Wiki) ![]() | |
| KE757: Altered hippocampal anatomy | Key Event | 757 (AOP-Wiki) ![]() | |
| KE758: Altered hippocampal physiology | Key Event | 758 (AOP-Wiki) ![]() | |
| KE851: Decreased GABAergic interneurons | Key Event | 851 (AOP-Wiki) ![]() | |
| Thyroid hormone biosynthesis pathway | Pathway | WP1981 (WikiPathways) ![]() |
Annotated Interactions
No annotated interactions
Saving...

